These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34286362)

  • 21. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.
    Chen Q; Jin M; Yang F; Zhu J; Xiao Q; Zhang L
    Mediators Inflamm; 2013; 2013():928315. PubMed ID: 23840100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases in lung diseases.
    Ohbayashi H
    Curr Protein Pept Sci; 2002 Aug; 3(4):409-21. PubMed ID: 12370004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis.
    Leeming DJ; Genovese F; Sand JMB; Rasmussen DGK; Christiansen C; Jenkins G; Maher TM; Vestbo J; Karsdal MA
    Respir Res; 2021 Feb; 22(1):38. PubMed ID: 33546680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.
    Paiva KBS; Granjeiro JM
    Prog Mol Biol Transl Sci; 2017; 148():203-303. PubMed ID: 28662823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases in liver injury, repair and fibrosis.
    Duarte S; Baber J; Fujii T; Coito AJ
    Matrix Biol; 2015; 44-46():147-56. PubMed ID: 25599939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.
    Moore L; Fan D; Basu R; Kandalam V; Kassiri Z
    Heart Fail Rev; 2012 Sep; 17(4-5):693-706. PubMed ID: 21717224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.
    Bonniaud P; Kolb M; Galt T; Robertson J; Robbins C; Stampfli M; Lavery C; Margetts PJ; Roberts AB; Gauldie J
    J Immunol; 2004 Aug; 173(3):2099-108. PubMed ID: 15265946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.
    Pauschinger M; Chandrasekharan K; Schultheiss HP
    Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases.
    Abraham D; Ponticos M; Nagase H
    Curr Vasc Pharmacol; 2005 Oct; 3(4):369-79. PubMed ID: 16248781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
    Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
    Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse functions of matrix metalloproteinases during fibrosis.
    Giannandrea M; Parks WC
    Dis Model Mech; 2014 Feb; 7(2):193-203. PubMed ID: 24713275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metaloproteinases in vascular pathology.
    Simões G; Pereira T; Caseiro A
    Microvasc Res; 2022 Sep; 143():104398. PubMed ID: 35671836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection.
    Kolloli A; Ramasamy S; Kumar R; Nisa A; Kaplan G; Subbian S
    Front Immunol; 2023; 14():1270414. PubMed ID: 37854602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis.
    Wu J; Chen L; Qin C; Huo F; Liang X; Yang X; Zhang K; Lin P; Liu J; Feng Z; Zhou J; Pei Z; Wang Y; Sun XX; Wang K; Geng J; Zheng Z; Fu X; Liu M; Wang Q; Zhang Z; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2022 Nov; 7(1):382. PubMed ID: 36424379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating markers of extracellular matrix remodelling in severe COVID-19 patients.
    Murphy SL; Halvorsen B; Holter JC; Huse C; Tveita A; Trøseid M; Hoel H; Kildal AB; Holten AR; Lerum TV; Skjønsberg OH; Michelsen AE; Aaløkken TM; ; Tonby K; Lind A; Dudman S; Granerud BK; Heggelund L; Bøe S; Dyrholt-Riise AM; Aukrust P; Barratt-Due A; Ueland T; Dahl TB
    J Intern Med; 2023 Dec; 294(6):784-797. PubMed ID: 37718572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.